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Summary of Future Tasks for the CGIAR Concerning Research Ethics. 
 
The Panel sees a need for common guidelines for the CGIAR concerning IPR, biodiversity, biosafety, 
handling of scientific dishonesty and handling and receiving of funding. The CGIAR should clarify 
existing guidelines and develop complementary guidelines where necessary. In particular, the CGIAR 
should set up a framework for handling complaints about serious scientific misconduct (cf. section 9). 
 The CGIAR has already issued statements and advice to Centers on Intellectual Property Rights 
and guidelines for the use of Genetic Resources. The Science Council has endorsed the 
recommendations from a study on biosafety. The Centers have developed guidelines for selected 
specific areas. The CIAT Code of Ethics covers a wide range of ethical issues. 
 The panel acknowledges these existing guidelines and advisory statements, which on their own 
terms appear very reasonable, balanced and thoughtful. The most important task for the CGIAR in the 
areas covered by the mentioned guidelines and advice is to systematize them and to complement them 
where necessary. Similarly, the individual Centers need to complement their guidelines and policies on 
research ethics related issues. 
 The panel further recommends that all research projects within the CGIAR are reviewed along 
the following lines: 
 
• Potential for contributing to the overall objective of the CGIAR (cf. section 1-2) 
• Potential links to implementation for end beneficiaries (cf. section 2) 
• Lifetime implications for stakeholders and plan for consultation, dialogue and involvement (cf. 
section 2) 
• Plan for dissemination (cf. section 3) 
• Biosafety issues and risk analysis (cf. section 8) 
• Ethical review of research with participation of vulnerable groups (cf. section 8) 
• Bioethical issues (cf. section 8) 
 
Each Center should set up a framework for such reviews. A possible framework would be a Standing 
Ethics Committee which has at least half of its members drawn from stakeholder bodies outside the 
Centre, and reports directly to the Centre Director General. A Standing Ethics Committee could also 
systematize and further develop advice and policies concerning good scientific practice (cf. section 9) 
and issues concerning IP (cf. section 6), biodiversity (cf. section 7) and funding (cf. section 10) and 
other ethics related issues for the centre. 
 In case the research involves human or animal subjects according to the definitions in sections 4-
5, the research protocol has to be reviewed by an appropriate review board. Each Center has to develop 
a framework for how to handle this. In case the Center does a lot of research on human subjects, it 
should have an Institutional Review Board like IFPRI; in other cases, it should find a suitable External 
Review Board. Similarly, for research on animals: in the case the Center does a lot of research on 
animals, it should have an Institutional Animal Care and Use Committee, like ILRI; in other cases, it 
should find a suitable external committee. 
 
 
 3
Introduction 
 
The present document aims to carry through one of the proposals made in an earlier Science Council-
commissioned report: “How should the CGIAR handle ethical challenges? - Issues and proposal for a 
strategic study”2. That report proposed (pp. 19-21) that the CGIAR should launch two separate studies 
of ethical issues of relevance for the CGIAR, one about “Research Ethics and the CGIAR”, and another 
on “Ethics and the CGIAR Mission”. The reason for treating the ethical issues in two separate studies 
stems roughly from the ethical distinction between ultimate goals and the process leading to these 
goals.  
 The proposed study about the CGIAR mission is envisaged to be concerned with the challenges 
and possibly conflicting ethical considerations involved in the ultimate goal of the CGIAR mission – to 
achieve food security and reduce poverty in developing countries. The issues center on how to balance 
cost efficiency in achieving food security and reducing poverty against the need to help the very poor, 
how to balance concern for the people living now and in the near future against concern for future 
generations, how to protect parts of nature that are production resources but at the same time may 
possess intrinsic value and how to develop capabilities, political rights, self esteem and initiative 
among the least privileged groups. 
 The present study is concerned with ethical issues relating to the process involved in the CGIAR 
mission – scientific research and research-related activities. Roughly, these ethical issues can be 
divided into three different categories: 
 The first is about the implications of the CGIAR’s overall objective for the way the research 
activities are conducted, i.e. the requirements of ensuring that the end beneficiaries of the research 
actually are benefited through dissemination of research results, through empowerment and through 
participation in relevant parts of the research process. Another implication is the requirement of 
ensuring a stable and transparent research process through dialogue and communication with the 
relevant stakeholders. 
 A second type of ethical issue is that relating to the parties affected by the research activities. 
These are, among others, human or animal research subjects, the environment and the general public. 
Important issues are concerned with ensuring that research results remain a public good and how to 
deal with intellectual property (IP) issues. Other important issues are biodiversity protection and 
biosafety. 
 The third types of issue relate to the ethical requirements internal to the conduct of research 
activities. These requirements include norms of good scientific practice and norms concerning the 
handling of funding. 
 The aim of the present document is to provide a review for the CGIAR on the ethical issues 
relating to the research process. Each section, except the first, is structured in three sub-sections. First, 
the background is presented, that is, a description of the issues of concern. Also, reference is made to 
relevant documents, comprising a review of CGIAR documents relating to the issues and reference to 
relevant international guidelines where they exist. Next, the fundamental values and principles are 
outlined, and potentially conflicting considerations are discussed. Then some more specific advice is 
derived from these principles. In some cases, the advice is to further develop existing CGIAR policies; 
in other cases, the advice is to adopt widely recognised international standards. Finally, in some cases, 
the advice is to develop new policies or structures, either individually as Centers or jointly. The report 
concludes in a summary (placed at the beginning) on future tasks for the CGIAR concerning research 
                                                 
2 “How should the CGIAR handle ethical challenges? - Issues and proposal for a strategic study”, prepared by Karsten Klint 
Jensen & Peter Sandøe for the SC of the CGIAR.  
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ethics; particularly, an overview of the recommendations about ethical review of research projects is 
provided.  
 The purpose of this review therefore is to sharpen the CGIAR’s attention to ethical 
considerations. The panel hopes to inspire Centers to develop more specific policies, either individually 
or jointly. It was not possible for the panel within the given time and resources to develop a full set of 
policies and guidelines to be adopted by the Centers. Also it is the conviction of the panel members that 
it is an important part of the exercise ahead for the Centers themselves to go the last part of the way. 
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A. IMPLICATIONS OF THE CGIAR’S OVERALL MISSION 
 
1. The Focus on Poverty 
 
The mission of the CGIAR is to achieve sustainable food security and reduce poverty in 
developing countries through scientific research and research-related activities in the 
fields of agriculture, livestock, forestry, fisheries, policy and natural resources 
management.3 
 
Values and Principles 
The most fundamental requirement is that the research is constructed to meet the avowed CGIAR goals 
in as efficient a way as possible. In other words, the research of the CGIAR should be relevant for the 
objective of achieving sustainable food security and reducing poverty in developing countries. Clearly, 
this requirement has a number of implications for the research process. Most importantly, there is a 
need to choose research topics of relevance for achieving the overall objective. This raises many 
questions of how to understand the objective in operational detail. For instance, how should poverty be 
defined and how should the poor be identified? How precisely is research in the fields of agriculture, 
livestock, forestry, fisheries, policy and natural resources management most effective in ensuring 
sustainable food security and reducing poverty for the poorest? However, we believe that these 
questions about the content of the research are so closely related to the ethics of the mission itself that 
we want to leave them for the second study. In the remaining part of the first section, we shall deal with 
other more formal requirements of the research process that derive from the overall objective of the 
CGIAR.  
 
 
2. Participation and Communication with Stakeholders 
 
Background 
The CGIAR charter defines stakeholders as “the broadest possible group of individuals and 
organizations that have a stake in agricultural research for development”.4 We should like to stress that, 
from an ethical point of view, stakeholders should be understood as the groups of individuals or 
organizations who affect, and/or are affected by CGIAR research and related activities. A rough outline 
of stakeholders includes members, partners and challenge program participants, donor organizations 
and donor countries, the end beneficiaries, local governments and local communities, national and 
international NGOs, national and international scientific communities within the fields of agriculture 
and development, private national and international enterprises or corporations, and national and 
international press.  
 In pursuing the objective of reducing poverty, hunger and malnutrition, the CGIAR Centers 
inevitably will be involved with controversial issues. One example could be research in, or even 
advocacy of using technologies, such as GM crops, that are perceived as controversial by some 
constituencies. Another example could be advocacy of policies with effects on traditional ways of life, 
such as local power relations or gender relations. In such cases, dialogue with local or international 
stakeholders on the choice of research areas or development of policies derived from the overall 
objective of the CGIAR system might be mutually beneficial. 
                                                 
3 CGIAR Charter, November 2004 
4 CGIAR Charter, November 2004, p. iv. 
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 In principle, all affected parties have a moral right of participation in the decision-making 
process. In this broad sense, ‘participation’ means having one’s interests considered. In some cases, 
there is a legal right of participation in a more formal sense as a right of being heard, or even a right to 
participate in meetings where decisions are made. In most cases, it is prudent to involve the affected 
parties in the decision-making process, because it increases the chance of decisions being robust and 
sustainable. However, it should be acknowledged that it is time-consuming and financially costly to 
involve others in the decision-making, and it could lead the decisions to vary from the overall objective 
of the research or impair efficiency. The problem is therefore: who should be involved, what should 
they be involved in, and how should they be involved?5 
 The CIAT Code of Ethics contains guidelines on public communication.6 It also has guidelines 
on research planning, implementation and dissemination. In planning and implementing research, it 
says, the ethical acceptability of the research should be reviewed according to the Code. 
 
Principles 
The general principle is that pursuit of the overall beneficial objective of the CGIAR should be 
constrained by choice of ethically acceptable means. Most important here is respect for the interests of 
the persons affected by the choice of means. This implies that the affected parties have the opportunity 
to give their consent to the means chosen in pursuit of the overall objective. Hence, there is a general 
duty to engage in open dialogue with the relevant stakeholders. 
 The main objective of the CGIAR Centers is to produce research results that will benefit the poor 
by reducing poverty, hunger and malnutrition sustainably, i.e., without increasing the risks that future 
generations will face poverty, hunger and malnutrition. Most important in relation to this goal are the 
potential beneficiaries. Firstly, there is the moral right of beneficiaries to participate effectively in 
decisions which affect their lives. The primary duty of the CGIAR is to benefit the poor through 
research; however, a secondary duty is to respect and possibly strengthen local autonomy through the 
implementation of research. The poor should, as far as possible, decide for themselves how their 
problems are to be solved. Secondly, involvement of the beneficiaries is clearly instrumental to achieve 
sustainable results of the research in relation to the goal of reducing poverty, hunger and malnutrition. 
A necessary condition for the research results to be effective is that the beneficiaries actually find such 
results relevant and useful and are willing to expend social energy in their implementation. Their 
interests should be taken into account throughout the agenda-setting, the decision-making processes 
and dissemination of knowledge. 
 
Advice 
From the initial planning phase, to the dissemination of research findings and implementation of 
practices informed by research results, there is a duty to make sure that there is a clear link to the end-
beneficiaries and their needs and wants. Early in the planning phase, it should be transparent how the 
research is directed towards the goal of contributing to the reduction of poverty, hunger and 
malnutrition in one way or another. Reasonable scenarios for the implementation of the results should 
be considered so as to maintain the link to the beneficiaries. Deciding the level of actual involvement, 
e.g. by local beneficiaries or relevant NGOs, is a matter of balancing the duty to respect the right to 
participation, and the potential benefits of doing so, against the duty to respect the integrity of science 
and not to make decision-making unduly time consuming or financially costly. It is the responsibility of 
the centre management to strike this balance in a fair way. The guiding principles should be to ensure 
                                                 
5 Relevant documents on participation include: The Universal Declaration of Human Rights, UN Declaration on the Right 
to Development, the International Covenant on Civil and Political Rights, the Convention on the Elimination of All Forms 
of Discrimination Against Women, and the African Charter for Popular Participation in Development 
6 CIAT Code of Ethics, 2005. 
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that involvement takes place where it adds important value – as compared with considering the affected 
parties’ interest; and furthermore, to seek out procedures for involvement that keep the costs of 
involvement in reasonable proportion to the added value.  
 Locally, it will be necessary to involve the beneficiaries in the decision making process. Local 
communities should be educated to ensure the necessary understanding of a policy and its implications. 
The Centers should develop policies for empowerment of local communities to ensure that every 
contact with local communities is governed by a thoroughly considered plan for how to respect and 
strengthen the beneficiaries’ autonomy.  
 In some cases, there will be conflict between pursuing the beneficial objective of the CGIAR 
most efficiently in the short term and perhaps costly and time-consuming procedures of respecting 
autonomy or setting up education schemes in order to ensure effective dissemination. In these cases, a 
reasonable balance has to be found. However, in striking this balance, the long term effects of 
autonomy and empowerment are likely to be helpful in relation to achieving the overall goal, and this 
should be taken into account. 
 Very early in the planning stages, research projects should be reviewed for their lifetime 
implications on other stakeholders, and the issues requiring dialogue with other stakeholders should be 
identified. Each CGIAR Center needs to develop policies for running an open dialogue with relevant 
stakeholders during the lifetime of a research project. This implies setting up routines for identifying 
relevant stakeholders, locally, as well as internationally. It also implies developing ways and channels 
to engage in dialogue with different types of relevant stakeholders.  
 In advocating the use of certain technologies, or the pursuit of certain policies, the Centers should 
always be transparent. This means that the normative and factual premises underlying the advocacy 
should be presented for all relevant stakeholders in a clear way. Particularly, the relation to the overall 
beneficial objective of reducing poverty, hunger and malnutrition should be apparent. In case some 
technology or policy advocated for by a centre involves heavy burdens on some group, there is a duty 
to ensure that this burden is distributed and shared in an equitable way.  
 
 
3. Dissemination 
 
Background 
It follows clearly from the CGIAR’s overall mission that research results, in order to be efficient, 
should be effectively disseminated to the potential end beneficiaries. Moreover, one of the seven planks 
that define the vision and strategy of the CGIAR, is that the CGIAR should strengthen its role as a 
"catalyst, integrator, and disseminator of knowledge within the overall global agricultural research 
system".7 Attainment of these goals requires effective communication of research results to a wide 
range of audiences. 
 ILRI has developed a data management policy8 with the purpose of archiving data in a form so 
they can be shared with other research groups and collaborating partners and be made available for 
integrated studies, long term studies, different sorts of publications, and for the scientific community 
and the general public. This could serve as a model for other CGIAR Centers. Also, the CIAT Code of 
Ethics contains guidelines on data sharing, on confidentiality and on dissemination.9 
                                                 
7 A Food Secure World for All: Toward a New Vision and Strategy for the CGIAR. TAC Secretariat, Food and Agricultural 
Organization of the United Nations, October 2002 
8 Data Management Policy (Draft-1), ILRI. 
9 CIAT Code of Ethics, 2005. 
 
 8
 
Principles 
As members of an organization with the goal of producing publically available research within the 
fields of agriculture, livestock, forestry, fisheries, policy and natural resources management, the 
CGIAR Centers have a duty to disclose all findings that might benefit the poor by reducing poverty, 
hunger and malnutrition, in a manner that reflects honesty and transparency in research goals and 
findings. The dissemination of knowledge should focus on, and be tailored to the following audiences, 
under the principle that all have the right to know: 
 
1. The scientific community. Research results and technical information should be 
communicated through scholarly, peer reviewed publication in order to provide an 
evidence-base for actions and policies, and a foundation for further research within the 
Center and by other scientists. Peer reviewed publication also serves as a basis for projected 
impact assessments, and as a source for evaluation and accountability of center activities. 
Collaboration in the preparation of research papers for publication is also important for 
building local research capacity.  
 In addition, with adequate protection of privacy and confidentiality, data and 
documentation should be shared in a timely manner so that it is available for other 
researchers and the general public. 
 
2. Governments, private enterprises and NGOs. These are the groups most likely to be able 
to act on research findings and thereby contribute to the goals of alleviating poverty and 
malnutrition in developing country contexts. While scholarly publications can be used for 
this purpose, a deliberate attempt to translate research findings into a more accessible 
format such as policy briefs and reports, is likely to be more effective. 
 
3. Potential beneficiaries of the research, which may include communities and individuals. 
Local organizations, communities, and individuals need information to inform practices 
that may lead to outcomes such as improved agricultural or economic productivity. Hence, 
there should be a focus on translation of scientific information into practical messages and 
communication in multiple modalities.  
 
Advice 
Dissemination of research results to the scientific community should follow the principles (though not 
necessarily the details for manuscript preparation, formatting, and submission) articulated in the 
Uniform Requirements for Manuscripts Submitted to Biomedical Journals,10 also known as the 
"Vancouver Rules", see Section 9. Decisions about when to disseminate information should balance 
urgency with careful evaluation of the scientific evidence.  
 Though peer-reviewed publication is necessary, it is not sufficient for achieving the CGIAR’s 
goal. The translation of scientific results and their communication to policy makers and the public is a 
responsibility as well as an important challenge. Researchers should consider partnering directly with 
individuals who have more expertise in communication with these groups. Special efforts should be 
made to develop content and modes of communication to maximize accessibility and comprehension 
for all stakeholders. Consideration should be given to the development of public education tools that 
are not reliant solely on text.  
                                                 
10 Uniform Requirements for Manuscripts Submitted to Biomedical Journals http://www.ICMJE.org 
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B. PARTIES AFFECTED BY THE RESEARCH ACTIVITIES 
 
 
4. Research on human subjects 
 
Background 
The Nuremberg trials at the end of World War II brought to light the horrors of experimentation on 
prisoners conducted by Nazi doctors and scientists, and identified an urgent need for standards to guide 
the ethical conduct of research involving human subjects. The Nuremberg Code11 established a legal 
standard for such research. In 1964, the World Medical Association reinterpreted and expanded the 
Code to include medical research with a therapeutic intent. This new code of research ethics came to be 
known as the Declaration of Helsinki.12 In the United States, the National Research Act of 1974 
established a National Commission for the Protection of Human Subjects of Biomedical and 
Behavioral Research, which, in the Belmont Report,13 articulated basic ethical principles and guidelines 
for the ethical conduct of research with human subjects. Federal regulations were implemented in the 
US to insure the protection of human subjects of biomedical and behavioral research. Similar national 
statutes guide the conduct of human subjects research in other countries, but not all countries have 
appropriate statutes. 
 Several organizations have addressed the need for international guidelines. Representatives from 
regulatory agencies and industry associations of the United States, Japan and Europe formed the 
International Conference on Harmonisation (ICH), to standardize the process by which new drugs are 
developed, tested and brought to market. Their Guideline for Good Clinical Practice14 establishes an 
“international ethical and scientific quality standard for designing, conducting, recording and reporting 
trials that involve human subjects.” Many pharmaceutical companies have voluntarily adopted these 
guidelines as the standard for conducting clinical trials. The Council for International Organizations of 
Medical Sciences (CIOMS), a non-government organization officially related to the World Health 
Organization and UNESCO has focused on the application of guidelines in developing countries. They 
have published International Ethical Guidelines for Biomedical Research Involving Human Subjects.15 
 The CIOMS guidelines identify a challenge of particular importance to the CGIAR. This is to 
“apply universal ethical principles ... in a multicultural world”. The guidelines take the position that 
human subject research must not violate any universally applicable ethical standards, but that the 
application of principles needs to take account of cultural values while respecting the absolute ethical 
principles. The guidelines emphasize the need for research conducted in developing countries to take 
account of factors which make the country or specific communities especially vulnerable to harm or 
exploitation from external scientific research. These include economic disparity, authoritative or 
corrupt political systems, lack of protection of human rights, lack of individual autonomy and lack of 
infrastructure for scientific/ethical review. Those who are involved in international research should 
therefore have some understanding of and sensitivity to the social, economic, and political milieu that 
frames the context in which their research is taking place. 
                                                 
11 The Nuremberg Code http://www.ushmm.org/research/doctors/Nuremberg_Code.htm 
12 The Declaration of Helsinki. http://www.wma.net/e/policy/b3.htm 
13 The Belmont Report http://www.hhs.gov/ohrp/humansubjects/guidance/belmont.htm 
14 International Conference on Harmonisation Guideline for Good Clinical Practice 
http://www.ich.org/MediaServer.jser?@_ID=482&@_MODE=GLB 
15 Council for International Organizations of Medical Sciences International Ethical Guidelines for Biomedical Research 
Involving Human Subjects (2002) http://www.cioms.ch/frame_guidelines_nov_2002.htm 
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 IFPRI has a document on the protection of human research subjects.16 The document states that 
the institute is guided by the ethical principles set forth in the Belmont Report. It is part of the 
institutional policy to have an Institutional Review Board. ICRAF has made policy guidelines on 
research ethics.17 Also these refer to the Belmont Report; however, they do not go into detail about 
ethical review of research. Also, the CIAT Code of Ethics18 contains guidelines for informed consent in 
research. Though the importance of an Institutional review Board or a similar body is mentioned, the 
guidelines does not set up standards for such a Board. 
 The present document presents standards that can provide for equivalent protections, while 
respecting local differences. 
 
Definitions: A working definition of human subjects research is needed to enable 
organizations to make judgments about activities to which the guidelines may apply. 
According to the Belmont Report, research is an “activity designed to test an hypothesis, 
permit conclusions to be drawn and thereby to develop or contribute to generalizable 
knowledge (expressed, for example in theories, principles and statements of relationships).” 
Research is described in a formal protocol that sets out objectives and procedures. Human 
subjects are living individuals about whom an investigator obtains data through 
intervention or interaction with the individual, or identifiable private information.  
 
In ordinary circumstances, the CGIAR is not involved in clinical research on patients. A typical kind of 
research that involves human subjects would be nutritional trials of biofortified staples produced by 
either conventional breeding or genetic engineering. Any negative impacts on health resulting from 
such trials would constitute a violation of that person’s right to health under the Universal Declaration 
on Human Rights and the International Covenant on Economic, Social and Cultural Rights. Another 
typical kind of research would be social science research with questionnaires involving identifiable 
private information. 
 
Principles 
All research involving the participation of human subjects should be guided by the following ethical 
principles:  
 
Respect for persons: This requires an acknowledgment of autonomy, or the individual’s 
freedom to choose whether or not to take part in research, in the absence of coercion. 
Respect for the human person mandates informed consent, a process for ensuring voluntary 
participation in research after being fully informed and comprehending all procedures, 
risks, and benefits. Respect for the human person also demands protection of individuals 
with diminished autonomy and for individuals who are cognitively, or otherwise impaired. 
 
Beneficence: Research should maximize benefits and minimize harm to participants.  
 
Justice: There should be equal sharing of the burdens and the benefits of research. The 
principle of justice has important implications for the selection of research subjects, with 
special care taken to avoid the exploitation of poor communities.  
                                                 
16 Principles, Policies and Procedures for the Protection of Human research Subjects at the International Food Policy 
Research Institute. Assurance of Compliance with Federal Regulations for the Protection of Reseach Subjects. IFPRI 2003. 
17 Research Ethics, ICRAF Policy Guidelines Series, 2004. 
18 CIAT Code of Ethics, 2005. 
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Advice 
 
Standards 
 
1) All research involving human subjects should be reviewed by a properly constituted ethical 
committee or Institutional Review Board and be approved by the committee before the research 
begins.  
 
a) The IRB/ethics committee should be comprised of a diverse group of individuals who possess 
expertise which allows them to understand the scientific merit as well as the ethical issues 
surrounding the research questions being addressed. Committee members should be familiar 
with the customs and traditions of the community in which the research is carried out. The 
committee members should be free from conflicts of interest, being independent of the 
investigator, the sponsor or any other undue influence. The committee should be in 
conformity with international law19, and the laws of the country in which it is operating.  
 An International Compilation of Human Subject Research Protections20 developed by the 
Office for Human Research Protections of the US Department of Health and Human Services 
identifies country-specific sources of information about laws, regulations, or guidelines 
pertaining to human subjects research.  
 
b) The IRB/ethics committee should conduct careful reviews of all protocols for human subjects 
research to determine that: 
• risks to participants are minimized and are reasonable in relation to benefits 
• there are adequate provisions for obtaining the informed consent of each individual 
research participant 
• participation is voluntary and free from coercion 
• there are adequate protections to maintain participants’ privacy and the confidentiality of 
information they provide  
• there are adequate protections for vulnerable individuals and populations (children, 
pregnant women, cognitively or otherwise impaired individuals, prisoners, members of 
disadvantaged communities)  
• there is an equitable distribution of burdens and benefits of research.  
 
c) Whenever possible, the IRB/ethics committee should be local to the research so that the views 
of persons knowledgeable about the prevailing community culture and norms can be taken 
into account. Ideally, each CGIAR constituent organization would have its own IRB/ethics 
committee or would establish an agreement with a local university or government committee. 
The committee should have expertise related to the range of research represented by the 
activities of the organization, be it clinical trials, or community based behavioral research. 
 
                                                 
19 Core International Human Rights Instruments are available at:  
http://www.ohchr.org/english/law/ 
20 Office for Human Research Protections, US Department of Health and Human Services (2005) International 
Compilation of Human Subject Research Protections  
http://www.hhs.gov/ohrp/international/HSPCompilation.pdf 
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d) For organizations wishing to develop their own committees, the Division of Ethics of Science 
and Technology of United Nations Educational, Scientific and Cultural Organization 
(UNESCO) has published a Guide for Establishing Ethics Committees21.  
 
2) Research should be conducted with a high level of vigilance and high standards of institutional 
accountability. Each institution conducting human subjects research should have a written, 
publicly available statement of its principles, policies and procedures for the protection of 
human research participants. Whenever research is conducted in collaboration with, or funded 
by a sponsor external to the performance site, the research should adhere to local laws as well as 
the procedures mandated by the sponsor’s country. Investigators from institutions outside of the 
country where research takes place must respect the ethical standards of their own countries and 
the cultural expectations of the societies in which studies are undertaken, unless this violates 
basic ethical principles. For example, research conducted in collaboration with, or funded by, 
the US must conform to 45 CFR 46, the Code of Federal Regulations22 that governs federally 
funded human subjects research.  
 
3) Institutions should have a policy and a means to provide for education in the ethical conduct of 
human subjects research for all personnel who may be involved in such research. Educational 
resources in several different languages are available. For example, many international 
organizations make reference to Family Health International's Research Ethics Training 
Curriculum for international scientists.23 24  
 
It should be noted that very poor people are particularly vulnerable and therefore require stronger 
protection. It is important to be aware of cases where there is doubt about whether consent is fully 
informed, e.g. due to illiteracy, or whether it is fully voluntary, e.g. because compensation for 
participation may imply that there is no free choice. In such cases, guardians should be appointed. 
 
 
5. Research on Animals 
 
Background 
Contemporary research in the life sciences involves experimentation on live animals. This research is 
considered an important tool in the progress of science. Within the CGIAR system and affiliated 
institutions animal experimentation is primarily used in studies relating to human nutrition, in studies 
concerning biosafety of products and in studies relating to livestock production and health. 
 However, dating back to the nineteenth century the use of live animals for experimentation has 
given rise to controversies relating to an underlying ethical problem: Animals are used as tools with the 
                                                 
21 "Guide for Establishing Ethics Committees", Division of Ethics of Science and Technology of United Nations 
Educational, Scientific and Cultural Organization (2005). 
http://unesdoc.unesco.org/images/0013/001393/139309e.pdf 
22 Code of Federal Regulations, Title 45 Public Welfare, Department of Health and Human Services, Part 46, Protection of 
Human Subjects, Revised June 23, 2005. http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.htm 
23 Versions are currently available in English, French, Spanish, and Portuguese 
http://www.fhi.org/en/RH/Training/trainmat/ethicscurr/index.htm. 
24 Web addresses and documents are cited as these are most easily accessed. In many cases, the cited documents are publicly 
available on many websites such as the CODEX Rules and Guidelines for Research 
http://www.codex.vr.se/codex_eng/codex/ and the US Office for Human Research Protections http://www.hhs.gov/ohrp/ 
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aim of protecting humans against illness or to improve their wealth or quality of life. In the process 
animals may in various ways be harmed. Thus it seems that we allow animals to be harmed with the 
aim of making life better for humans. Even though the end may be good, it may be debated from an 
ethical point of view whether the end justifies the means. 
 In Europe, Northern America and Australasia the problem has been dealt with in the following 
way: Animal use is accepted, provided that care is taken to consider alternative means of achieving the 
same result, that care is taken to keep the animals under good conditions, and that great effort is put 
into designing experiments so that results can be achieved with no or a minimum of suffering for the 
animals. A parallel reason speaking in favour of good animal care is that lack of care leads to unreliable 
research results. 
 There are significant differences in legislation, regulations and policies across the continents. In 
Europe there is a system with binding rules enforced by governments, whereas in the US there is a 
more flexible system based on the idea of local Animal Care and Use Program that should be complied 
with by every individual and institution involved in animal experimentation.25 
 ILRI has an Institute Animal Care and Use Commmittee. The panel is not aware of the guidelines 
set up for this committee; however, the committee has produced a detailed manual for Standard 
Operating Procedures for Animal Experimentation26 to ensure animal welfare. The ICRAF guidelines 
on research Ethics27 refer to the standards and pratices developed by ILRI to be used when research has 
animal welfare implications. 
 
Principles 
Animals should be respected as sentient beings. Animal experimentation is only acceptable when 
substantial human benefits are at stake and animal suffering is minimised. The three Rs proposed by 
Russell and Burch28 – the replacement of existing experiments with animal-free alternatives, or 
reductions in the number of animals used, or refined methods that cause animals less suffering – should 
guide animal researchers to ensure that animal suffering is minimised.  
 
Advice 
Whenever animal experiments are conducted at CGIAR institutions or at other institutions financed by 
CGIAR funds, they must be regulated by governmental authority set up for the purpose or within an 
Animal Care and Use Program in accordance with the following standards.  
 
Standards 
An Animal Care and Use Program must cover at least the following elements:29 
                                                 
25 Relevant documents:  
Bayne, K & deGreeve, P: An Overview of Global Legislation, Regulation, and Policies on the Use of Animals for Scientific 
Research, Testing, or Education, in Hau, J & Van Hoosier, GL (eds.) Handbook of Laboratory Animal Science, Second 
Edition: Essential Principles and Practices, Vol. I, Chapter 2, pp 13-31, 2002: CRC Press LLC, USA. 
Animal Procedures Committee (2003). Review of cost-benefit assessment in the use of animals in research. Home Office, 
Communication Directorate: London. www.apc.gov.uk 
26 Standard Operating Procedures for Animal Experimentation, lasted version by ILRI Institute Animal Care and Use 
Committee, 2004. 
27 Research Ethics, ICRAF Policy Guidelines Series, 2004. 
28 Russell, W.M.S. and Burch, R.L., The Principles of Humane Experimental Technique, London: Methuen, 1959.  
29 For more detailed descriptions of how to fill out the standards, reference should be made to one of the following guides: 
ARENA (Applied Research Ethics National Association) and OLAW (Office of Laboratory Animal Welfare), NIH (2002). 
Institutional animal care and use committee guidebook. Second edition. OLAW, NIH: Bethesda, MD. 
ftp://ftp.grants.nih.gov/IACUC/GuideBook.pdf 
Australian Government National Health and Medical Research Council (2004). Australian code of practice for the care and 
use of animals in scientific procedures. Australian Government. 
http://www7.health.gov.au/nhmrc/publications/synopses/ea16syn.htm 
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An Institutional Animal Care and Use Committee. This committee should review all 
proposed uses of animals and has the responsibility for oversight and evaluation of the 
entire animal care and use program and facilities. The committee should consist of a 
minimum of five members. Of these at least one should be Doctor of Veterinary Medicine, 
at least one should be a practicing animal-research scientist, at least one should be a non-
scientist; and at least one should not be affiliated with the institution in question. The 
committee should receive administrative support and should refer directly to the top 
management of the institute. 
 
Education. All members of the Institutional Animal Care and Use Committee, all 
researchers responsible for animal experimentation, and all staff directly involved in 
handling and care of the animals should receive proper education and training. This should 
ensure that those responsible for animal experimentation are up to date with developments 
in experimental methodology, bearing in mind particularly the design of alternative 
methods. Those responsible for the housing and daily care of laboratory animals will 
ideally be equipped with a thorough understanding of the behavioural and physiological 
needs of the relevant animal species and know how to implement various form of 
environmental enrichment. 
 
Adequate veterinary care. At every facility where animal experimentation takes place there 
must be a veterinarian who has the authority to oversee key components of the Animal Care 
and Use program.  
 
 
6. Intellectual Property Rights 
 
Background 
The CGIAR mission demands that the Centers can operate freely and can produce research results as 
international public goods. However, the situation is becoming difficult as a result of new national IPR 
regimes, rising local private sector investment in developing countries, and increases in the export of 
agricultural products based on proprietary science. The increasing importance of intellectual property 
rights (IPR) and proprietary science is leading to greater investment by the private sector in agricultural 
research (especially in the applications of modern biotechnology), but also to the commercialisation of 
the processes and the commodification of the products of such research 
 Given the importance of IPR, it is not surprising that the CGIAR has developed detailed guiding 
principles. There has also been a study on IPR strategies.30 In addition, several centers have made 
statements.31 However, there are several versions of the CGIAR guidelines. The most complete version 
                                                                                                                                                                       
New Zealand National Animal Ethics Advisory Committee (2002). Good practice guide for the use of animals in research, 
testing and teaching. MAF: Wellington.http://www.biosecurity.govt.nz/animal-welfare/naeac/papers/guide-for-animals-
use.pdf  
30 Strategies for the CGIAR to Conduct Research and Deliver Technological Innovation that Benefit the Poor in a Context 
of Intellectual PropertyRights., 2005. 
31 Policy of the International Crops Research Institute for the Semi-Arid Tropics (ICRISAT) on Intellectual property Rights 
(IPR). ILRI’s Policy on Intellectual Property Rights, Biosafety and Bioethics, 2000. Assessment of Third Party Property 
related to the Challenge Program on Water and Food.  
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seems to be the one quoted as an annex in the ICRISAT statement.32 The present panel confirms its 
support to the policy inherent in these guidelines. We shall quote some of the underlying values. 
 
Principles 
“The management of intellectual property by Centers will be guided by the CGIAR mission to 
contribute to food security and poverty eradication in developing countries through research, 
partnerships, capacity building and policy support. The Centers will manage intellectual property issues 
with integrity, equity, responsibility and accountability.”  
 
Advice 
• The CGIAR does not view the protection of intellectual property as a mechanism for securing 
financial returns upon which it may depend. To the extent that such returns are generated, they will 
be used in support of specific tasks and projects fully compatible with the CGIAR mission and 
objectives. 
• The CGIAR promotes ready access to breeding material for breeding and research activities. 
Subject to the paragraph below, the CGIAR regards any information, inventions, processes, 
biological material or other research products funded or developed by the CGIAR or the Centers 
(research products) as international public goods to be used in furtherance of its mission. Full and 
timely disclosure of research results and products in the public domain is the preferred strategy for 
preventing misappropriation by others. 
• Recognizing there may be times when using intellectual property is a necessary or preferred means 
to pursue CGIAR and Center objectives, Centers may consider acquiring and managing intellectual 
property in research products developed or funded by the Center when to do so would 
a) support public and private partnerships which pursue mission-based research or which develop 
and apply research results; 
b) assure ready access by others to research products developed or funded by the Center; 
c) ensure the Center's ability to pursue its research, together with its partners, without undue 
hindrance; 
d) facilitate the transfer of technology, research products and other benefits to the resource poor 
including, where appropriate, through commercialization or utilization or research products; 
and/or 
e) facilitate the negotiation and conclusion of agreements for access to proprietary technologies of 
use to the Center's research and in furtherance of its mission. 
 
The CGIAR has a duty to engage the private sector, universities, advanced research institutes, National 
Agricultural Research Systems, and other organizations to use the Centers’ research products in order 
to bring them to bear on the opportunities of poor people. The CGIAR should actively negotiate to 
minimize any restrictions of third party IP for innovative technology associated with its mission, and 
that which may benefit people in developing countries. Engagement with the private sector should 
follow the guidelines outlined in Section 10. 
 
 
 
 
                                                 
32 ICRISAT Guiding Principles on Management of Intellectual Property Annex I, 2000. 
http://www.icrisat.org/ip_management/policy.htm  
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7. Biodiversity 
 
Background 
Perhaps no single input is as important to the work of the CGIAR as genetic resources. Hence, the 
CGIAR has been playing a leading role internationally, regarding plant and animal genetic resources 
and biodiversity.  
 Ethical issues relating to genetic resources and biodiversity include erosion and species loss; bio-
prospecting; collection, characterization and conservation (both in situ and ex situ) of genetic 
resources; ownership and control of and access to plant genetic resources and to improvements; 
equitable access and sharing of the benefits deriving from plant genetic resources; and the patenting of 
plant genetic resources. 
 The issue of biodiversity is regulated by the Convention on Biological Diversity. The issue of 
genetic resources was the first area, in which the CGIAR made a statement on ethical principles.33 The 
CGIAR guidelines on IPR also covers the issue of genetic resources.34 
 
Principles 
The guiding principle is the CGIAR’s commitment to maintain genetic materials and bio-control agents 
in its collections in the public domain and to ensure access to, and free and equitable exchange of such 
materials. Designated germplasm is held in trust for the world community and the CGIAR is obliged to 
conserve, maintain, study, improve, and distribute germplasm world-wide for use in agricultural 
research and development. The CGIAR has a responsibility for safe and secure conservation of these 
In-Trust genetic materials for present and future generations, including their duplication in at least one 
other location for safety. 
 The CGIAR recognizes the contributions of farming and indigenous communities to the 
conservation and enhancement of local genetic resources. The CGIAR furthermore recognizes the right 
of these communities to benefit from these resources. However, the CGIAR is also committed by its 
duty to ensure equitable access to genetic resources and cannot, as a general rule, support exclusive 
rights for particular communities. 
 Utilizing local genetic resources sometimes conflicts with the duty to respect wildlife and to 
protect valuable non-cultivated areas. The CGIAR should encourage solutions that minimize such 
conflicts. 
 
Advice 
The CGIAR is in principle committed to regard any information, inventions, processes, biological 
material or other research products funded or developed by CGIAR as international public goods to be 
used in furtherance of its mission. To achieve this in practice some measures to protect intellectual 
property rights may be required to be put in place. The CGIAR should promote ready access to 
breeding materials for breeding and research activities; where appropriate this should include new 
genetically modified varieties that can be made available when they are off patent (and perhaps even 
when they are on patent by licensing at nominal rates). The CGIAR encourages germplasm donors to 
permit the designation of material in accordance with the 1994 agreements with FAO.35 
                                                 
33 CGIAR’s Ethical Principles Relating to Genetic Resources. 
www.cgiar.org/corecollection/docs/sgrp_policy_booklet_2003.pdf 
34 ICRISAT Guiding Principles on Management of Intellectual Property Annex I, 2000. 
http://www.icrisat.org/ip_management/policy.htm  
35 The FAO-CGIAR Agreement on Genetic Resources. The FAO International Undertaking of Plant Genetic Resources for 
Food and Agriculture. 
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 The CGIAR recognizes the expertise of many national and international NGOs on equity, gender, 
conservation, sustainability, and nature protection issues. The CGIAR therefore commits itself to 
engage in dialogue with these organisations according to the principles outlined in Section 2, and can, 
where appropriate, form partnerships with them to integrate these concerns in research on genetic 
resources. 
 
 
8. Biosafety and Risks 
 
Background 
Biosafety is an issue clearly important to the CGIAR. A panel on biosafety reported in 2002 to the SC 
of the CGIAR36 and made 12 specific recommendations: 
 
• Enhance CGIAR Centre Biosafety Policies 
• Enhance Capacity Building in National Biosafety Policies and Practices  
• Strengthen Centre Capacity in Biosafety Practice and Research through Pro-active Approaches to 
Biosafety  
• Develop an Integrated Approach to the Practice of Biosafety in the Centers  
• Establish a CGIAR System Biosafety Network  
• Increase Biosafety-related Research by the Centers  
• Publish and Communicate Results of Biosafety Research 
• Prepare for Forestry and Fisheries Biosafety Issues  
• Undertake more Risk/benefit Analysis  
• Develop Plans for Preparing Risk Assessment Dossiers for Product Approval  
• Better Address Bioethical Issues 
• Initiate a CGIAR System-wide Biosafety Workshop to Plan Implementation of the Biosafety Panel’s 
Recommendations  
 
The present panel acknowledges the ongoing work in this area. Particularly, we note the panel 
recommended that the Centers should “better address bioethical issues”, and to this purpose, the panel 
further recommended that each centre maintain a standing ethical committee to give advice on 
biosafety. This report was endorsed in principle by the Science Council, but the means by which the 
CGIAR might proceed to implementation was qualified in an SC Commentary. The present panel fully 
approves of the recommendations and shall not add any further advice in this respect. However, it 
might be useful, in context of these guidelines, to clearly state the underlying values in the concern for 
biosafety. 
 An area of special concern is the risk of unintended effects of CGIAR research. Examples could 
be farmers’ participation in participatory breeding or resource management experiments which alter the 
efficacy of former genetic or natural resource use by the participants involving risks of greater reliance 
on monocropping, unsustainable input levels and the like. Another example could be community 
management experiments involving a risk of gradual exclusion of people rather than inclusion. Even 
though such research does not, in the technical sense, involve human subjects, some of the same doubts 
about informed consent can arise here: Does the poor farmer understand the risk of participating? Is 
there a truly free choice? 
                                                 
36 Report of the Biosafety Panel to the CGIAR Science Council on Biosafety Policy and Practices of the CGIAR Centers 
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 We should also like to mention the CIAT Code of Ethics,37 which states that “CIAT scientists 
takes steps to implement protections for the rights and welfare of research participants and other 
persons affected by the research” and “In planning and implementing research CIAT scientists consult 
those with expertise concerning any special population or agroecosystem under investigation or likely 
to be affected”.  
 
Principles 
The general principle at stake here is that the duty to benefit the poor is constrained by the principle of 
respect for persons. Biosafety becomes an ethical issue for the CGIAR because a technology or a 
policy used in the pursuit of the objective of reducing poverty, hunger and malnutrition often to some 
degree involves risks of unwanted outcomes. It is wrong to sacrifice individuals in the pursuit of 
benefiting the poor. It is also wrong to expose others to serious risk of harm in the pursuit of benefiting 
the poor. Similarly, it is wrong to harm the environment or to expose the environment to serious risk of 
harm. 
 In the case of Genetically Modified Organisms (GMOs), these risks are often regulated, such that 
GMOs only can be approved in cases where a risk assessment has demonstrated that the risk of 
unwanted effects is acceptably low. However, as the SC rightly points out in its comments to the report 
on biosafety, there are biosafety issues, and thus ethical problems, also for traditional types of breeding, 
even though they are not regulated. 
 Another issue concerns uncertainty about how well a means will achieve the overall objective of 
reducing poverty, hunger and malnutrition. Thus, certain technologies or policies might involve serious 
risks, e.g. of an environmental catastrophe, and thereby endanger the long term achievement of the 
overall objective. Through its commitment to sustainable development, the CGIAR clearly has a duty 
to adopt a precautionary approach which seeks to find beneficial solutions that avoids unnecessary risk-
taking in the short term and which obviates endangering future possibilities of reducing poverty, 
hunger and malnutrition. 
 The Precautionary Principle, as it is used in most contexts, is a principle allowing governments to 
enforce restrictions or bans on technologies or products not just in case of a scientifically documented 
harmful effects at an unacceptable level on human health or the environment, but also when there is a 
scientifically based worry of such harmful effects. What we mean by a precautionary approach, in this 
context, is an approach where the agent, when comparing relevant alternatives of action including 
doing nothing, seeks to avoid unjustified risks or unduly high stake risks. Clearly, in very poor 
countries, a continuation of the status quo is very likely to have serious harmful effects in terms of 
continued poverty, hunger or malnutrition. The risk of alternatives to the status quo should be judged in 
the light of this fact; however, there is still reason to be aware of risks and particularly to avoid high 
stake risks for future generations. 
 
Advice 
Biosafety issues should always be handled through dialogue with the relevant stakeholders as outlined 
in Section 2, in order to choose means where the risk of harm to others or to the environment is 
acceptably low for all affected parties. National regulation of risks should of course always be 
respected. 
 Ethically speaking, in the areas not regulated, there is no clear limit for how serious a risk of 
harm must be before it is wrong to expose others to it without their consent. Thus, in some cases there 
could be a dilemma, when the risk for others in question is considered low, and the consequence of 
avoiding running the risk is a serious constraint on achieving the objective of benefiting the poor. In 
                                                 
37 CIAT Code of Ethics, 2005. 
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such cases, the balancing between the concern for biosafety and the duty to benefit the poor should 
involve the affected stakeholders. 
 Research involving participation by vulnerable groups, e.g. very poor farmers, should be 
reviewed by an ethical review board, and guardians should be appointed where necessary. 
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C. THE INTERNAL SCIENTIFIC PROCESS 
 
9. Good Scientific Practice 
 
Background 
Science has evolved from ideals such as truth, objectivity, openness and rationality. Scientists are 
brought up to respect these ideals of science throughout their education. However, massive structural 
changes pose challenges for maintaining the integrity of science. Scientists are involved in hard 
competition to get funding, and therefore they are under a strong pressure to present results. Scientists 
also have become increasingly specialised, and they are almost exclusively evaluated by their peer-
reviewed international publications. Hence, an increasing number of scientists may be tempted to 
engage in dishonesty or even fraud in the production and presentation of scientific results in order to 
pursue their career interests. Problems with scientific dishonesty include practices such as fabrication 
of data, misleading or distorting interpretation or presentation of results, plagiarism and inappropriate 
credit for authorship.  
 ICRAF has produced a good discussion paper which makes it clear that scientific dishonesty is a 
possibility of which the CGIAR Centers have to be aware.38 The CIAT Code of Ethics contains 
guidelines for a number of issues like scientific standards, competence, use and misuse of expertise, 
delegation and supervision, non-discrimination and non-exploitation, harassment, employment 
decisions, conflicts of interest.39 The code also has guidelines for reporting of research, plagiarism, 
authorship credit, publication and review, and education and training. 
 
Principles 
The fundamental value at stake is the integrity of science. Ideally speaking, science is the search for the 
truth through rational and openly documented procedures, serving all mankind. If individual scientists 
seek to further personal interests through deceitful or fraudulent conduct, the integrity of science is 
threatened, because the scientific enterprise as a whole is called into question. The integrity of science 
builds on the fact that scientific results are open for public scrutiny. But it is also dependent on the 
integrity of scientists. Scientists must be reliable in their production and presentation of results. Hence, 
science as an institution needs to protect its integrity by fostering good scientific practice among 
scientists. Also, it needs to detect scientific dishonesty and seek to eliminate it from the scientific 
corpus. 
 
Advice 
The Centers need to state and enforce clear policies on good scientific practice. We recommend that the 
CGIAR formulate common policies on the presentation of research protocols, data documentation and 
data storage, and interpretation, presentation and publication of results. The Ryan Commission Report 
on Research Integrity40 provides guidelines on these issues. 
 In order to ensure adherence to the norms of good scientific practice throughout the CGIAR 
system, we suggest that the policies be taught in training courses for the staff. It is the responsibility of 
supervisors to ensure that the norms of good scientific practice are known and adhered to by the entire 
staff. This also implies that supervisors motivate staff by making sure they understand the context and 
reasons for the work. Unreasonable requests or work loads should not be imposed. 
                                                 
38 ICRAF: Scientific Fraud, Research Discussion Paper 1.  
39 CIAT Code of Ethics, 2005. 
40 Integrity and Misconduct in research: Report of the Commission on Research Integrity, 
http://www.faseb.org/opar/cri.html  
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Concerning authorship and publication, we suggest the CGIAR adopt the Vancouver rules41 as its 
standard for good scientific practice. While this guidance was developed for biomedical publications, 
the principles relating to ethical considerations in the conduct and reporting of research and aspects of 
publishing, and editorial issues related to publication are applicable to all scientific disciplines. In 
relation to authorship, the main point of these guidelines are: 
  
Authorship credit should be based on 1) substantial contributions to conception and design, or 
acquisition of data, or analysis and interpretation of data; 2) drafting the article or revising it 
critically for important intellectual content; and 3) final approval of the version to be published. 
Authors should meet conditions 1, 2, and 3. 
 
It is particularly important that the contribution of all members of the research team, including local 
and external scientists and non-research partners be appropriately credited, either through authorship, 
contributorship or formal acknowledgement. An author shall have contributed substantially to the 
research process, s/he shall have contributed substantially to the preparation of the manuscript and s/he 
shall take responsibility for appropriate portions of the content. We recommend that a comprehensive 
co-author statement should be prepared and signed by all authors, describing precisely the nature and 
extent of each author’s contribution without using stereotypical language 
 Also, the CGIAR should have a formal system to which complaints about serious scientific 
misconduct can be lodged for investigation and judgment. We recommend that the CGIAR set up 
common rules for the handling of scientific fraud. These rules should prescribe an independent 
committee, based within the Science Council, to which substantial doubts about the honesty or integrity 
of a work can be referred and appropriately pursued. The committee should conduct a full investigation 
and make a determination adhering to due process standards. The rules should also describe the 
relevant sanctions in the event of demonstrable fraudulent behaviour.  
 
 
 
10. Handling and Receiving Funding 
 
Background 
Objectivity and integrity of researchers are essential values in scientific research, and form the basis for 
public trust. A conflict of interest arises when a researcher or employee of an organization has 
competing professional and personal obligations or financial interests that would make it difficult to 
fulfill his or her duties objectively.  
  Within the CGIAR, activities related to improvement of commodities, plant and animal genetics 
such as plant breeding for improved micronutrient content of foods have potential for economic gains 
and thus require careful scrutiny. Concerns are raised when financial considerations may compromise 
or have the appearance of compromising an investigator's professional judgment and independence in 
the design, conduct, or publication of research. As for receiving funding, a principal question is how to 
deal with such conflicts of interests. 
 The CGIAR’s internal funding decisions concern the use to which funds are put, particularly 
prioritizing between research fields. The CGIAR also makes funding decisions when it choose between 
partners in Challenge Programs though running competitive tenders. We envisage two types of 
                                                 
41 Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical 
Publication. http://www.ICMJE.org 
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conflicts concerning the handling of funding within the CGIAR system. One is concerned with the 
cases where a scientist or Board of Trustee Member within the CGIAR is both a potential receiver of 
funding and member of a funding committee. The other is the conflict between funding allocated 
through open competition and funding allocated to special issues or to the benefit of special areas or the 
like. The general trend is that more and more funding is allocated through open competition, because 
open competition is believed to be the best guarantee for scientific quality and freedom from conflict of 
interest.  
 ICLARM (now the WorldFish Center) has a policy on partnerships42 which states guidelines for 
collaboration with partners such as government and non-government national institutions, advanced 
scientific institutions, regional and international organisations, research centers, individual scientists, 
the private sector and participating farmers or fishers. Similar guidelines would be useful for all 
Centers. The CIAT Code of Ethics43 contains guidelines on conflicts of interest and contractual and 
consulting services. 
 
Principles 
Is important to avoid not only actual conflicts of interest, but also apparent and potential conflicts in 
order to maintain the public's trust. Concerning receipt of funding, the guiding principle should be that 
the CGIAR only accepts such funding if it is compatible with the overall mission of the CGIAR and the 
duty to keep research a public good. In all cases of funding and collaboration, there should be 
transparent declaration of interests from the involved parties. 
 Funding decisions within the CGIAR system should be free from conflict of interest, and the 
process by which decisions are made should be transparent. Decisions about funding should consider 
the duties and responsibilities of the CGIAR to all of the communities that it serves. First and foremost, 
the CGIAR has the duty to do research that actually benefits the poor. Second, the CGIAR has a duty to 
do the best science possible and to strengthen the scientific capacity in local communities. Finally, the 
CGIAR has a duty to choose the most cost-effective means to benefit the poor through 
methodologically sound science.  
 
 
 
Advice 
Centers should maintain a written policy on conflict of interest which is enforced to protect the 
integrity of the scientific process, the missions of the institutions, the investment of stakeholders in 
institutions and public confidence in the integrity of research. This policy should establish requirements 
for disclosures of conflict of interest. 
Evaluation of the potential for conflict of interest should be part of the review of research 
protocols conducted by institutional review boards or ethics committees, since the protection of human 
subjects requires objectivity in communicating risks, selecting subjects, promoting informed consent, 
and gathering, analyzing and reporting data. As for funding from the private sector, we believe the 
Alliance of Future Harvest Centers of the CGIAR has provided useful guidelines:44 
 
                                                 
42 Policy on Partnerships in Research and Related Activities, ICLARM. 
43 CIAT Code of Ethics, 2005. 
 
44 Alliance of Future Harvest Centers of the CGIAR: “Guidelines for center modes of collaboration with the private sector”, 
May 2005, WorldFish Center, Penang, Malaysia. 
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As such, fund raising is not the focus for collaboration with the private sector but, rather, 
partnerships with the private sector will be entered into when they serve to enhance the 
capability of the Center to deliver to its stakeholders and collaborators the best quality science 
aimed at meeting the Center and CGIAR objectives and goals. 
• The CGIAR policy on these matters is that we will enter into such arrangements only if they 
complement and enhance a Center’s ability to achieve its mandate of service to the resource-
poor and the environment. In simple terms, will a particular agreement help us to more 
quickly develop new, appropriate technologies and/or deliver them to beneficiaries in 
developing countries? 
•  Wherever possible, the terms of the collaboration will be consistent with the International 
Public Good’s basis of the Center’s work and the use of its products. Where products of the 
partnership cannot be so protected, the Center will ensure that our target beneficiaries, the 
poor in developing countries, can gain from the products of the partnership.  
• As the nature of the CGIAR changes to include more research arrangements with advanced 
research institutes both public and private we believe that it is important that the best efforts 
should be exercised to ensure that the major partners are well informed of the arrangements 
with the private sector. 
• Private sector collaborations will be governed by appropriate, time-bound legal contracts 
and memoranda of agreement which will clearly define the Center’s obligations and protect 
the Center from potential liabilities; 
• Where other major research partners have been directly involved in research and related 
activities of relevance to the private sector partnership, best efforts should be exercised to 
obtain the agreement of these partners before entering into arrangements with the private 
sector; 
• The Center will follow good business practices such as efficient use of resources, respect for 
legal contracts and confidentiality provisions. In the specific area of IP the Centers shall act 
in a manner fully consistent with national and international law in this area, while ensuring 
that issues such as exclusive licensing is only adopted when clearly consistent with the best 
interests of its beneficiaries as indicated in other provisions of these guidelines. 
• Centers will not accept funding from private companies that could reasonably create a 
conflict of interests or in any way compromise the objectivity of the results of work carried 
out.  
Staff within the CGIAR system participating in committees that allocate funding have a duty to declare 
any real or potential conflict of interest. Persons whose conflicting interests may raise questions about 
their ability to make fair decisions should withdraw from decisions about funding, on their own 
initiative. 
 In general, scientific quality is best served by allocating funding through open competition. 
However, there might be cases, where funding to an important and potentially beneficial topic cannot 
be allocated through open competition, because there is only one competent research group within the 
area. In these cases, it should be possible to allocate earmarked funding directly. However, it is 
important to note that all science – including science funded through earmarked money – should be 
reviewed for quality, i.e. through peer review from independent experts. Regardless of how this 
balancing plays out, it is important that the CGIAR is transparent about the conflicting values at stake 
and how the balance is struck in a particular instance.  
 
 
